Latest by Terri Wilder, M.S.W.

Christopher Ferraris, LMSW

Helping Providers Increase Capacity to Care for Patients on PrEP

A poster presentation at the AIDS 2018 conference examined some of the challenges and barriers providers experience in screening and prescribing PrEP to their patients.

Lynne Mofenson, M.D., at AIDS 2018 in Amsterdam, the Netherlands (Credit: Terri Wilder)

Lynne Mofenson, M.D., Explains the Dolutegravir Risks for People With HIV Who Want to Get Pregnant

New information was presented at the 2018 International AIDS Conference in Amsterdam about babies born with neural tube defects to women with HIV who started a regimen with dolutegravir (Tivicay, DTG) and then later got pregnant.

David Barr

HIV Activist David Barr on Going Beyond 90-90-90

Barr, a longtime AIDS activist and co-founder of Treatment Action Group (TAG), was the coordinator for the Joep Lange Institute's AIDS 2018 preconference workshop, Meeting the 90-90-90 Targets: Faster and Better.

Anthony Fauci, M.D.

Anthony Fauci Discusses Research Approaches to Sustaining HIV Remission Without Antiretroviral Therapy

Fauci spoke to TheBodyPRO at this year's International AIDS Conference on approaches to HIV remission and durable control of HIV without antiretroviral therapy.

Anthony Fauci, M.D.

Anthony Fauci Traces the HIV Research Path to U=U

At this year's AIDS 2018 in Amsterdam, Fauci detailed the scientific research that lead us on the path to the discovery that undetectable equals untransmittable (U=U).

Anton Pozniak at the 90-90-90 Targets Workshop

How Will Long-Acting HIV Antiretrovirals Work in the Real World?

Once viable long-acting HIV prevention and treatment options have reached the market, what will be their true impact? Leading HIV clinician-researcher Anton Pozniak, M.D., shares his expertise.

Promo Image

Are Current PrEP Guidelines and HIV Risk-Screening Tools Accurate?

Terri Wilder, M.S.W., spoke with John Schneider, M.D., M.P.H., author of a study that examined how accurate current guidelines for identifying PrEP candidates and risk-screening tools are among a group of young Black men who have sex with men.

Man holding a wrapped condom.

Condoms and the Double Standard in Prescribing PrEP

Could a provider's personal beliefs about condom use affect their willingness to prescribe PrEP? One study surveyed U.S. medical students and found bias in terms of willingness to offer PrEP based on clinical situations.

Implementation of a Rapid HIV Diagnostic and Referral Strategy Img
CROI (Conference on Retroviruses and Opportunistic Infections)

Implementation of a Rapid HIV Diagnostic and Referral Strategy

One study in Amsterdam deployed a strategy to identify acute HIV in men who have sex with men (MSM) and then link newly diagnosed individuals to care.

Opt-Out HIV and HCV Testing at the Dallas County Jail Img
CROI (Conference on Retroviruses and Opportunistic Infections)

Opt-Out HIV and HCV Testing at the Dallas County Jail

One study set out to examine how effective opt-out testing for HIV and hepatitis C (HCV) could be among individuals who entered the Dallas County jail.